Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / FUL - H.B. Fuller Reports Fourth Quarter and Fiscal Year 2023 Results


FUL - H.B. Fuller Reports Fourth Quarter and Fiscal Year 2023 Results

Q4 Reported EPS (diluted) of $0.80; Adjusted EPS (diluted) of $1.32, up 27% year-on-year
Company achieves new record for Q4 and fiscal year adjusted EBITDA margin
Q4 Adjusted EBITDA up 22% and Adjusted EBITDA margin up 440 basis points versus Q4 2022
FY 2023 cash flow from operations increased 48% year-on-year to $378 million

H.B. Fuller Company (NYSE: FUL) today reported financial results for its fourth quarter and fiscal year that ended December 2, 2023.

Fourth Quarter 2023 Noteworthy Items:

  • Achieved strong profit growth and record fourth quarter adjusted EBITDA margin on exceptional execution and proactive response to significant customer destocking activity throughout the year;
  • Net revenue was $903 million, down 5.8% year-on-year; net revenue was up 1.2% year-on-year on a 13-week comparable basis; organic revenue decreased 3.5% year-on-year, driven by slightly lower pricing and volume;
  • Gross margin was 30.3%; adjusted gross margin of 31.3% increased 510 basis points year-on-year, driven by pricing and raw material cost actions and restructuring benefits;
  • Net income was $45 million; adjusted EBITDA was $173 million, up 22% year-on-year, and adjusted EBITDA margin expanded 440 basis points year-on-year to 19.1%;
  • Reported EPS (diluted) was $0.80; adjusted EPS (diluted) was $1.32, up 27% versus the prior year, driven by strong operating income growth;
  • Net working capital, as a percentage of annualized net revenue, decreased 200 basis points sequentially from 18.1% in the third quarter to 16.1% in the fourth quarter;
  • Net debt-to-adjusted EBITDA ratio declined sequentially from 3.3X to 2.9X driven both by lower net debt and growth in adjusted EBITDA.

Summary of Fourth Quarter 2023 Results:

The Company’s net revenue for the fourth quarter of fiscal 2023 was $903 million, down 5.8% versus the fourth quarter of fiscal 2022. Organic revenue declined 3.5% year-on-year, with pricing adjustments reducing organic revenue by 3.4% and volume reducing organic revenue by 0.1%. Foreign currency translation increased net revenue by 0.3%, acquisitions increased net revenue by 4.4%, and the impact of one less week during the fourth quarter reduced net revenue by 7.0%. Net revenue increased 1.2% year-on-year on a comparable 13-week basis in the fourth quarter.

Gross profit in the fourth quarter of fiscal 2023 was $274 million. Adjusted gross profit was $283 million. Adjusted gross profit margin of 31.3% increased 510 basis points year-on-year. Pricing and raw material cost actions, restructuring benefits and general cost reductions drove the increase in adjusted gross margin year-on-year.

Selling, general and administrative (SG&A) expense was $160 million in the fourth quarter of fiscal 2023 and adjusted SG&A was $156 million, effectively flat year-on-year. Continued cost management and additional restructuring benefits offset inflation in wages and services and the incremental SG&A costs associated with acquisitions completed over the previous year.

Net income attributable to H.B. Fuller for the fourth quarter of fiscal 2023 was $45 million, or $0.80 per diluted share. Adjusted net income attributable to H.B. Fuller for the fourth quarter of fiscal 2023 was $74 million. Adjusted EPS was $1.32 per diluted share, up 27% year-on-year driven by strong operating income growth.

Adjusted EBITDA in the fourth quarter of fiscal 2023 was $173 million, up 22.4% year-on-year. Adjusted EBITDA margin increased 440 basis points year-on-year to 19.1%, driven by the balance of raw material and price movements versus the prior year’s fourth quarter, as well as restructuring savings. This year’s fourth quarter had one less week versus the prior year’s fourth quarter and this unfavorably impacted adjusted EBITDA growth by approximately $10 million.

“I am proud of our leaders for exceptional execution throughout the year, as evidenced by strong profit growth and record margins. Across the organization, our teams proactively managed the changing price and raw material dynamics successfully and implemented decisive restructuring measures in the face of unprecedented customer destocking, which we believe is largely behind us, to deliver these results and position H.B. Fuller for continued future profit growth, margin expansion and strong cash flow,” said Celeste Mastin, H.B. Fuller president and chief executive officer.

“As the market leader in innovation, focused on providing highly customized solutions for our customers, we have successfully transformed our portfolio into one that is concentrated in the highly specified areas of our market segments. As such, we have begun to take our portfolio management approach to the next level by proactively driving capital allocation to the highest margin, highest growth market segments. We have compelling growth opportunities in front of us and we are confident in our capabilities to continue to transform H.B. Fuller and achieve an adjusted EBITDA margin target greater than 20 percent within the next 3 to 5 years.

“As we enter fiscal year 2024, we are confident in our outlook for positive organic growth and achieving further EBITDA margin expansion. We are successfully executing our strategy to deploy capital to the highest return opportunities, innovating with speed to deliver solutions for our customers, driving efficiencies throughout our manufacturing footprint, and achieving meaningful synergies from our collections of acquisitions.”

Fiscal Year 2023 Noteworthy Items:

  • Achieved record fiscal year adjusted EBITDA margin on exceptional execution and proactive response to significant customer destocking activity throughout the year;
  • Net revenue was $3.51 billion, down 6.4% year-on-year; on a 52-week comparable basis, net revenue was down 4.6% year-on-year; organic revenue decreased 5.5% year-on-year, driven by 8.4% lower volume due to significant customer destocking activity during the year, offset somewhat by 2.9% favorable pricing;
  • Gross margin was 28.7%; adjusted gross margin of 29.4% increased 350 basis points year-on-year, driven by pricing and raw material cost actions and restructuring benefits;
  • Net income was $145 million; adjusted EBITDA was $581 million, up 10% year-on-year; adjusted EBITDA margin expanded 240 basis points year-on-year to a fiscal year record high of 16.5%;
  • Reported EPS (diluted) was $2.59; adjusted EPS (diluted) was $3.87, down slightly versus the prior year, as strong operating income growth nearly offset significantly higher net interest expense and unfavorable foreign currency exchange which reduced adjusted EPS (diluted) by $0.58 and $0.18, respectively;
  • Cash flow from operations of $378 million improved $122 million year-on-year, or 48%, on improved profitability and lower net working capital requirements.

Balance Sheet and Working Capital:

Net debt at the end of the fourth quarter of fiscal 2023 was $1,659 million, down $131 million sequentially versus the third quarter and down $26 million year-on-year. The sequential reduction in net debt, together with growth in adjusted EBITDA, reduced the ratio of net debt-to-adjusted EBITDA from 3.3X to 2.9X sequentially.

Net working capital in the fourth quarter of fiscal 2023 declined $74 million sequentially versus the third quarter and $58 million year-on-year. As a percentage of annualized net revenue, net working capital declined 200 basis points sequentially, and 180 basis points year-on-year on a comparable 52-week basis, to 16.1%.

Fiscal 2024 Outlook:

  • Net revenue growth for fiscal 2024 is expected to be in the range of up 2% to 6% with organic revenue flat to up 3% versus fiscal 2023, reflecting a rebound in demand following the unprecedented customer destocking activity in fiscal 2023, offset by slightly lower pricing as customers qualify lower price formulations and index-based pricing has a greater effect;
  • Adjusted EBITDA for fiscal 2024 is expected to be in the range of $610 million to $640 million, equating to growth of approximately 5% to 10% year-on-year;
  • The core tax rate, excluding the impact of discrete items, is anticipated to be between 27% and 28% in fiscal year 2024;
  • Net interest expense for fiscal 2024 is expected to be between $115 million and $125 million;
  • Adjusted EPS (diluted) is expected to be in the range of $4.15 to $4.45, equating to a range of up 7% to 15% year-on-year;
  • Operating cash flow in fiscal year 2024 is expected to be between $300 million and $350 million and capital expenditures are expected to be approximately $140 million.

Conference Call:

The Company will hold a conference call on January 18, 2024, at 9:30 a.m. CT (10:30 a.m. ET) to discuss its results. Interested parties may listen to the conference call on a live webcast. The webcast, along with a supplemental presentation, may be accessed from the Company’s website at https://investors.hbfuller.com . Participants must register prior to accessing the webcast using this link and should do so at least 10 minutes prior to the start of the call to install and test any necessary software and audio connections. A telephone replay of the conference call will be available from 12:30 p.m. CT on January 18, 2024, to 10:59 p.m. CT on January 25, 2024. To access the telephone replay dial 1-800-770-2030 (toll free) or 1-647-362-9199, and enter Conference ID: 6370505.

Regulation G

The information presented in this earnings release regarding consolidated and segment organic revenue growth, operating income, adjusted gross profit, adjusted gross profit margin, adjusted selling, general and administrative expense, adjusted income before income taxes and income from equity investments, adjusted income taxes, adjusted effective tax rate, adjusted net income, adjusted diluted earnings per share and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) does not conform to U.S. generally accepted accounting principles (U.S. GAAP) and should not be construed as an alternative to the reported results determined in accordance with U.S. GAAP. Management has included this non-GAAP information to assist in understanding the operating performance of the Company and its operating segments as well as the comparability of results to the results of other companies. The non-GAAP information provided may not be consistent with the methodologies used by other companies. All non-GAAP information is reconciled with reported U.S. GAAP results in the “Regulation G Reconciliation” tables in this press release with the exception of our forward-looking non-GAAP measures contained above in our Fiscal 2023 Outlook, which the Company cannot reconcile to forward-looking GAAP results without unreasonable effort.

About H.B. Fuller

Since 1887, H.B. Fuller has been a leading global adhesives provider focusing on perfecting adhesives and sealants to improve products and lives. With fiscal 2023 net revenue of $3.5 billion, H.B. Fuller’s commitment to innovation and sustainable adhesive solutions brings together people, products and processes that answer and solve some of the world's biggest challenges. Our reliable, responsive service creates lasting, rewarding connections with customers in electronics, disposable hygiene, medical, transportation, aerospace, clean energy, packaging, construction, woodworking, general industries and other consumer businesses. Our promise to our people connects them with opportunities to innovate and thrive. For more information, visit us at https://www.hbfuller.com .

Safe Harbor for Forward-Looking Statements

Certain statements in this press release may be considered forward-looking statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “opportunity,” “outlook,” “plan,” “project,” “seek,” “should,” “strategy,” “target,” “will,” “will be,” “will continue,” “will likely result,” “would” and similar expressions, and variations or negatives of these words or phrases. These statements are subject to various risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including but not limited to the following: the availability and pricing of raw materials; the impact of potential cybersecurity attacks and security breaches; the impact on the supply chain, raw material costs and pricing of our products due to military conflict, including between Russia and Ukraine and Israel and Hamas; the consequences of the COVID-19 outbreak and other pandemics on our operations and financial results; the impact on our margins and product demand due to inflationary pressures; the substantial amount of debt we have incurred to finance our acquisition of Royal, our ability to repay or refinance our debt or to incur additional debt in the future, our need for a significant amount of cash to service and repay the debt and to pay dividends on our common stock, the effect of debt covenants that limit the discretion of management in operating the business or in paying dividends; our ability to pay dividends and to pursue growth opportunities if we continue to pay dividends according to our current dividend policy; our ability to acquire and integrate complementary businesses; our ability to achieve expected synergies, cost savings and operating efficiencies from our restructuring initiatives and operational improvement projects within the expected time frames or at all; our ability to effectively implement Project ONE; uncertain political and economic conditions; fluctuations in product demand; competing products and pricing; our geographic and product mix; disruptions to our relationships with our major customers and suppliers; failures in our information technology systems; regulatory compliance across our global footprint; trade policies and economic sanctions impacting our markets; changes in tax laws and tariffs; devaluations and other foreign exchange rate fluctuations; the impact of litigation and investigations, including for product liability and environmental matters; impairment charges on our goodwill or long-lived assets; the effect of new accounting pronouncements and accounting charges and credits; and similar matters.

Additional information about these various risks and uncertainties can be found in the “Risk Factors” section of our Form 10-K filings, and any updates to the risk factors in our Form 10-Q and 8-K filings with the SEC, but there may be other risks and uncertainties that we are unable to identify at this time or that we do not currently expect to have a material impact on the business. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law.

H.B. FULLER COMPANY AND SUBSIDIARIES

CONSOLIDATED FINANCIAL INFORMATION

In thousands, except per share amounts (unaudited)

Three Months
Ended

Three Months
Ended

December 2,

Percent of

December 3,

Percent of

2023

Net Revenue

2022

Net Revenue

Net revenue

$

902,879

100.0

%

$

958,213

100.0

%

Cost of sales

(629,037

)

(69.7

)%

(710,092

)

(74.1

)%

Gross profit

273,842

30.3

%

248,121

25.9

%

Selling, general and administrative expenses

(160,440

)

(17.8

)%

(157,872

)

(16.5

)%

Other income, net

4,918

0.5

%

251

0.0

%

Interest expense

(33,297

)

(3.7

)%

(30,046

)

(3.1

)%

Interest income

1,217

0.1

%

1,609

0.2

%

Income before income taxes and income from equity method investments

86,240

9.6

%

62,063

6.5

%

Income taxes

(42,274

)

(4.7

)%

(15,163

)

(1.6

)%

Income from equity method investments

1,036

0.1

%

1,429

0.1

%

Net income including non-controlling interest

45,002

5.0

%

48,329

5.0

%

Net income attributable to non-controlling interest

(11

)

(0.0

)%

(24

)

(0.0

)%

Net income attributable to H.B. Fuller

$

44,991

5.0

%

$

48,305

5.0

%

Basic income per common share attributable to H.B. Fuller

$

0.83

$

0.90

Diluted income per common share attributable to H.B. Fuller

$

0.80

$

0.87

Weighted-average common shares outstanding:

Basic

54,491

53,824

Diluted

56,161

55,472

Dividends declared per common share

$

0.205

$

0.190

H.B. FULLER COMPANY AND SUBSIDIARIES

CONSOLIDATED FINANCIAL INFORMATION

In thousands, except per share amounts (unaudited)

Year Ended

Year Ended

December 2,

Percent of

December 3,

Percent of

2023

Net Revenue

2022

Net Revenue

Net revenue

$

3,510,934

100.0

%

$

3,749,183

100.0

%

Cost of sales

(2,502,037

)

(71.3

)%

(2,785,484

)

(74.3

)%

Gross profit

1,008,897

28.7

%

963,699

25.7

%

Selling, general and administrative expenses

(653,760

)

(18.6

)%

(640,981

)

(17.1

)%

Other income, net

9,682

0.3

%

12,952

0.3

%

Interest expense

(134,602

)

(3.8

)%

(91,521

)

(2.4

)%

Interest income

3,943

0.1

%

7,779

0.2

%

Income before income taxes and income from equity method investments

234,160

6.7

%

251,928

6.7

%

Income taxes

(93,529

)

(2.7

)%

(77,186

)

(2.1

)%

Income from equity method investments

4,357

0.1

%

5,665

0.2

%

Net income including non-controlling interest

144,988

4.1

%

180,407

4.8

%

Net income attributable to non-controlling interest

(82

)

(0.0

)%

(94

)

(0.0

)%

Net income attributable to H.B. Fuller

$

144,906

4.1

%

$

180,313

4.8

%

Basic income per common share attributable to H.B. Fuller

$

2.67

$

3.37

Diluted income per common share attributable to H.B. Fuller

$

2.59

$

3.26

Weighted-average common shares outstanding:

Basic

54,332

53,580

Diluted

55,958

55,269

Dividends declared per common share

$

0.805

$

0.738

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands, except per share amounts (unaudited)

Three Months Ended

Year Ended

December 2,

December 3,

December 2,

December 3,

2023

2022

2023

2022

Net income attributable to H.B. Fuller

$

44,991

$

48,305

$

144,906

$

180,313

Adjustments:

Acquisition project costs 1

4,765

1,822

16,874

10,830

Organizational realignment 2

10,549

1,471

29,900

6,386

Royal restructuring and integration 3

-

1,467

-

2,474

Project One

2,193

2,326

9,815

9,885

Other 4

(3,903

)

4,524

(611)

12,791

Discrete tax items 5

16,955

1,610

26,085

9,308

Income tax effect on adjustments 6

(1,158

)

(3,911

)

(10,604

)

(10,699

)

Adjusted net income attributable to H.B. Fuller 7

74,392

57,614

216,365

221,288

Add:

Interest expense

33,297

30,046

131,913

91,547

Interest income

(1,217

)

(1,609

)

(3,943

)

(7,790

)

Income taxes

26,477

17,464

78,047

78,576

Depreciation and Amortization expense 8

39,653

37,469

158,456

146,394

Adjusted EBITDA 7

172,602

140,984

580,838

530,015

Diluted Shares

56,161

55,472

55,958

55,269

Adjusted diluted income per common share attributable to H.B. Fuller 7

$

1.32

$

1.04

$

3.87

$

4.00

Adjusted net revenue

$

902,879

$

958,213

$

3,510,934

$

3,749,183

Adjusted EBITDA margin 7

19.1

%

14.7

%

16.5

%

14.1

%

1 Acquisition project costs include costs related to integrating and accounting for acquisitions.

2 Organizational realignment includes costs incurred as a direct result of the organizational realignment program, including compensation for employees supporting the program, consulting expense and operational inefficiencies related to the closure of production facilities and consolidation of business activities.

3 Royal restructuring and integration program includes costs incurred as a direct result of the Royal restructuring and integration program including compensation for employees supporting the program, consulting expense and operational inefficiencies related to the closure of production facilities and consolidation of business activities.

4 Other expenses for the year ended December 3, 2022, include a $3.3 million non-cash charge related to the wind down and settlement of the Company’s Canadian defined benefit pension plan, $1.3 million of hedging costs related to the Russian ruble devaluation driven by the war in Ukraine, $1.2 million of transactional tax expense associated with an audit settlement, other expenses for COVID-19 testing, vaccinations and exceptional medical claims, and non-cash gains and losses related to legal entity consolidations.

5 Discrete tax items for the year ended December 2, 2023 are related to the tax impact of withholding tax recorded on earnings that are no longer permanently reinvested, as well as other various U.S. and foreign tax matters. Discrete tax items for the year ended December 3, 2022 are related to the revaluation of cross-currency swap agreements due to depreciation of the Euro versus the U.S. Dollar, as well as various foreign tax matters offset by the tax effect of legal entity mergers.

6 The income tax effect on adjustments represents the difference between income taxes on net income before income taxes and income from equity method investments reported in accordance with U.S. GAAP and adjusted net income before income taxes and income from equity method investments.

7 Adjusted net income attributable to H.B. Fuller, adjusted diluted income per common share attributable to H.B. Fuller, adjusted EBITDA and adjusted EBITDA margin are non-GAAP financial measures. Adjusted net income attributable to H.B. Fuller is defined as net income before the specific adjustments shown above. Adjusted diluted income per common share is defined as adjusted net income attributable to H.B. Fuller divided by the number of diluted common shares. Adjusted EBITDA is defined as net income before interest, income taxes, depreciation, amortization and the specific adjustments shown above. Adjusted EBITDA margin is defined as adjusted EBITDA divided by net revenue. The table above provides a reconciliation of adjusted net income attributable to H.B. Fuller, adjusted diluted income per common share attributable to H.B. Fuller, adjusted EBITDA and adjusted EBITDA margin to net income attributable to H.B. Fuller, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

8 Depreciation and amortization expense added back for EBITDA is adjusted for amounts already included in adjusted net income attributable to H.B. Fuller totaling ($1,036) and ($1,384) for the three and twelve months ended December 2, 2023, respectively and ($123) and ($582) for the three and twelve months ended December 3, 2022, respectively.

H.B. FULLER COMPANY AND SUBSIDIARIES

SEGMENT FINANCIAL INFORMATION

In thousands (unaudited)

Three Months Ended

Year Ended

December 2,

December 3,

December 2,

December 3,

2023

2022

2023

2022

Net Revenue:

Hygiene, Health and Consumable Adhesives

$

411,085

$

443,528

$

1,601,487

$

1,695,934

Engineering Adhesives

365,735

395,053

1,428,744

1,532,639

Construction Adhesives

126,059

119,632

480,703

520,610

Corporate unallocated

-

-

-

-

Total H.B. Fuller

$

902,879

$

958,213

$

3,510,934

$

3,749,183

Segment Operating Income:

Hygiene, Health and Consumable Adhesives

$

65,614

$

42,836

$

215,088

$

165,786

Engineering Adhesives

57,539

53,607

187,346

168,873

Construction Adhesives

3,772

957

5,961

22,989

Corporate unallocated

(13,523

)

(7,151

)

(53,258

)

(34,930

)

Total H.B. Fuller

$

113,402

$

90,249

$

355,137

$

322,718

Adjusted EBITDA 7

Hygiene, Health and Consumable Adhesives

$

81,677

$

57,684

$

275,802

$

223,988

Engineering Adhesives

74,020

70,487

255,778

235,948

Construction Adhesives

15,933

14,571

55,517

74,187

Corporate unallocated

972

(1,758

)

(6,259

)

(4,108

)

Total H.B. Fuller

$

172,602

$

140,984

$

580,838

$

530,015

Adjusted EBITDA Margin 7

Hygiene, Health and Consumable Adhesives

19.9

%

13.0

%

17.2

%

13.2

%

Engineering Adhesives

20.2

%

17.8

%

17.9

%

15.4

%

Construction Adhesives

12.6

%

12.2

%

11.5

%

14.3

%

Corporate unallocated

NMP

NMP

NMP

NMP

Total H.B. Fuller

19.1

%

14.7

%

16.5

%

14.1

%

NMP = non-meaningful percentage

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands, except per share amounts (unaudited)

Three Months Ended

Year Ended

December 2,

December 3,

December 2,

December 3,

2023

2022

2023

2022

Income before income taxes and income from equity method investments

$

86,240

$

62,063

$

234,160

$

251,928

Adjustments:

Acquisition project costs 1

4,765

1,822

16,874

10,830

Organizational realignment 2

10,549

1,471

29,900

6,386

Royal restructuring and integration 3

-

1,467

-

2,474

Project One

2,193

2,326

9,815

9,885

Other 4

(3,903

)

4,524

(611

)

12,791

Adjusted income before income taxes and income from equity method investments 9

$

99,844

$

73,673

$

290,138

$

294,294

9 Adjusted income before income taxes and income from equity investments is a non-GAAP financial measure. Adjusted income before income taxes and income from equity investments is defined as income before income taxes and income from equity investments before the specific adjustments shown above. The table above provides a reconciliation of adjusted income before income taxes and income from equity investments to income before income taxes and income from equity investments, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands, except per share amounts (unaudited)

Three Months Ended

Year Ended

December 2,

December 3,

December 2,

December 3,

2023

2022

2023

2022

Income Taxes

$

(42,274

)

$

(15,163

)

$

(93,529

)

$

(77,186

)

Adjustments:

Acquisition project costs 1

(405

)

(613

)

(3,127

)

(2,767

)

Organizational realignment 2

(898

)

(495

)

(5,206

)

(1,635

)

Royal restructuring and integration 3

-

(494

)

-

(707

)

Project One

(187

)

(783

)

(1,848

)

(2,067

)

Other 4

332

(1,526

)

(422

)

(3,522

)

Discrete tax items 5

16,955

1,610

26,085

9,308

Adjusted income taxes 10

$

(26,477

)

$

(17,464

)

$

(78,047

)

$

(78,576

)

Adjusted income before income taxes and income from equity method investments

$

99,844

$

73,673

$

290,138

$

294,294

Adjusted effective income tax rate 10

26.5

%

23.7

%

26.9

%

26.7

%

10 Adjusted income taxes and adjusted effective income tax rate are non-GAAP financial measures. Adjusted income taxes is defined as income taxes before the specific adjustments shown above. Adjusted effective income tax rate is defined as income taxes divided by adjusted income before income taxes and income from equity method investments. The table above provides a reconciliation of adjusted income taxes and adjusted effective income tax rate to income taxes, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands (unaudited)

Three Months Ended

Year Ended

December 2,

December 3,

December 2,

December 3,

2023

2022

2023

2022

Net revenue

$

902,879

$

958,213

$

3,510,934

$

3,749,183

Gross profit

$

273,842

$

248,121

$

1,008,897

$

963,699

Gross profit margin

30.3

%

25.9

%

28.7

%

25.7

%

Adjustments:

Acquisition project costs 1

529

738

3,146

1,058

Organizational realignment 2

8,136

1,211

18,108

3,207

Royal restructuring and integration 3

-

329

-

706

Project ONE

223

-

223

6

Other 4

52

472

530

1,830

Adjusted gross profit 11

$

282,782

$

250,871

$

1,030,904

$

970,506

Adjusted gross profit margin 11

31.3

%

26.2

%

29.4

%

25.9

%

11 Adjusted gross profit and adjusted gross profit margin are non-GAAP financial measures. Adjusted gross profit and adjusted gross profit margin is defined as gross profit and gross profit margin excluding the specific adjustments shown above. The table above provides a reconciliation of adjusted gross profit and gross profit margin to gross profit and gross profit margin, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands (unaudited)

Three Months Ended

Year Ended

December 2,

December 3,

December 2,

December 3,

2023

2022

2023

2022

Selling, general and administrative expenses

$

(160,440

)

$

(157,872

)

$

(653,760

)

$

(640,981

)

Adjustments:

Acquisition project costs 1

4,236

1,084

13,831

9,772

Organizational realignment 2

2,333

260

11,712

4,393

Royal restructuring and integration 3

-

1,138

-

1,794

Project ONE

1,969

2,326

9,592

9,879

Other 4

(3,954

)

(408

)

(3,882

)

2,284

Adjusted selling, general and administrative expenses 12

$

(155,856

)

$

(153,472

)

$

(622,507

)

$

(612,859

)

12 Adjusted selling, general and administrative expenses is a non-GAAP financial measure. Adjusted selling, general and administrative expenses is defined as selling, general and administrative expenses excluding the specific adjustments shown above. The table above provides a reconciliation of adjusted selling, general and administrative expenses to selling, general and administrative expenses, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands (unaudited)

Three Months Ended:

Hygiene,
Health
and
Consumable

Engineering

Construction

Corporate

H.B. Fuller

December 2, 2023

Adhesives

Adhesives

Adhesives

Total

Unallocated

Consolidated

Net income attributable to H.B. Fuller

$

67,438

$

58,857

$

5,682

$

131,977

$

(86,986

)

$

44,991

Adjustments:

Acquisition project costs 1

-

-

-

-

4,765

4,765

Organizational realignment 2

-

-

-

-

10,549

10,549

Royal restructuring and integration 3

-

-

-

-

-

-

Project One

-

-

-

-

2,193

2,193

Other 4

-

-

-

-

(3,903)

(3,903)

Discrete tax items 5

-

-

-

-

16,955

16,955

Income tax effect on adjustments 6

-

-

-

-

(1,158

)

(1,158

)

Adjusted net income attributable to H.B. Fuller 7

67,438

58,857

5,682

131,977

(57,585

)

74,392

Add:

Interest expense

-

-

-

-

33,297

33,297

Interest income

-

-

-

-

(1,217

)

(1,217

)

Income taxes

-

-

-

-

26,477

26,477

Depreciation and amortization expense 8

14,239

15,163

10,251

39,653

-

39,653

Adjusted EBITDA 7

$

81,677

$

74,020

$

15,933

$

171,630

$

972

$

172,602

Adjusted net revenue

$

411,085

$

365,735

$

126,059

$

902,879

-

902,879

Adjusted EBITDA margin 7

19.9

%

20.2

%

12.6

%

19.0

%

NMP

19.1

%

Year Ended

Hygiene,
Health
and
Consumable

Engineering

Construction

Corporate

H.B. Fuller

December 2, 2023

Adhesives

Adhesives

Adhesives

Total

Unallocated

Consolidated

Net income attributable to H.B. Fuller

$

222,404

$

192,635

$

13,602

$

428,641

$

(283,735

)

$

144,906

Adjustments:

Acquisition project costs 1

-

-

-

-

16,874

16,874

Organizational realignment 2

-

-

-

-

29,900

29,900

Royal restructuring and integration 3

-

-

-

-

-

-

Project One

-

-

-

-

9,815

9,815

Other 4

-

-

-

-

(611)

(611)

Discrete tax items 5

-

-

-

-

26,085

26,085

Income tax effect on adjustments 6

-

-

-

-

(10,604

)

(10,604

)

Adjusted net income attributable to H.B. Fuller 7

222,404

192,635

13,602

428,641

(212,276

)

216,365

Add:

Interest expense

-

-

-

-

131,913

131,913

Interest income

-

-

-

-

(3,943

)

(3,943

)

Income taxes

-

-

-

-

78,047

78,047

Depreciation and amortization expense 8

53,398

63,143

41,915

158,456

-

158,456

Adjusted EBITDA 7

$

275,802

$

255,778

$

55,517

$

587,097

$

(6,259

)

$

580,838

Adjusted net revenue

1,601,487

1,428,744

480,703

$

3,510,934

-

3,510,934

Adjusted EBITDA margin 7

17.2

%

17.9

%

11.5

%

16.7

%

NMP

16.5

%

Note: Adjusted EBITDA is a non-GAAP financial measure. The table above provides a reconciliation of adjusted EBITDA for each segment to net income attributable to H.B. Fuller for each segment, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

NMP = Non-meaningful percentage

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands (unaudited)

Three Months Ended:

Hygiene,
Health
and
Consumable

Engineering

Construction

Corporate

H.B. Fuller

December 3, 2022

Adhesives

Adhesives

Adhesives

Total

Unallocated

Consolidated

Net income attributable to H.B. Fuller

$

45,913

$

55,900

$

3,460

$

105,273

$

(56,968

)

$

48,305

Adjustments:

Acquisition project costs 1

-

-

-

-

1,822

1,822

Organizational realignment 2

-

-

-

-

1,471

1,471

Royal restructuring and integration 3

-

-

-

-

1,467

1,467

Project One

-

-

-

-

2,326

2,326

Other 4

-

-

-

-

4,524

4,524

Discrete tax items 5

-

-

-

-

1,610

1,610

Income tax effect on adjustments 6

-

-

-

-

(3,911

)

(3,911

)

Adjusted net income attributable to H.B. Fuller 7

45,913

55,900

3,460

105,273

(47,659

)

57,614

Add:

Interest expense

-

-

-

-

30,046

30,046

Interest income

-

-

-

-

(1,609

)

(1,609

)

Income taxes

-

-

-

-

17,464

17,464

Depreciation and amortization expense 8

11,771

14,587

11,111

37,469

-

37,469

Adjusted EBITDA 7

$

57,684

$

70,487

$

14,571

$

142,742

$

(1,758

)

$

140,984

Adjusted net revenue

$

443,528

$

395,053

$

119,632

$

958,213

-

$

958,213

Adjusted EBITDA margin 7

13.0

%

17.8

%

12.2

%

14.9

%

NMP

14.7

%

Year Ended

Hygiene,
Health
and
Consumable

Engineering

Construction

Corporate

H.B. Fuller

December 3, 2022

Adhesives

Adhesives

Adhesives

Total

Unallocated

Consolidated

Net income attributable to H.B. Fuller

$

177,614

$

177,641

$

32,474

$

387,729

$

(207,416

)

$

180,313

Adjustments:

Acquisition project costs 1

-

-

-

-

10,830

10,830

Organizational realignment 2

-

-

-

-

6,386

6,386

Royal restructuring and integration 3

-

-

-

-

2,474

2,474

Project One

-

-

-

-

9,885

9,885

Other 4

-

-

-

-

12,791

12,791

Discrete tax items 5

-

-

-

-

9,308

9,308

Income tax effect on adjustments 6

-

-

-

-

(10,699

)

(10,699

)

Adjusted net income attributable to H.B. Fuller 7

177,614

177,641

32,474

387,729

(166,441

)

221,288

Add:

Interest expense

-

-

-

-

91,547

91,547

Interest income

-

-

-

-

(7,790

)

(7,790

)

Income taxes

-

-

-

-

78,576

78,576

Depreciation and amortization expense 8

46,374

58,307

41,713

146,394

-

146,394

Adjusted EBITDA 7

$

223,988

$

235,948

$

74,187

$

534,123

$

(4,108

)

$

530,015

Adjusted net revenue

$

1,695,934

$

1,532,639

$

520,610

$

3,749,183

-

$

3,749,183

Adjusted EBITDA margin 7

13.2

%

15.4

%

14.3

%

14.2

%

NMP

14.1

%

Note: Adjusted EBITDA is a non-GAAP financial measure. The table above provides a reconciliation of adjusted EBITDA for each segment to net income attributable to H.B. Fuller for each segment, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

NMP = Non-meaningful percentage

H.B. FULLER COMPANY AND SUBSIDIARIES

SEGMENT FINANCIAL INFORMATION

NET REVENUE GROWTH (DECLINE)

(unaudited)

Net revenue growth versus 2022

Three Months
Ended

Year Ended

December 2,
2023

December 2,
2023

Price

(3.4

)%

2.9

%

Volume

(0.1

)%

(8.4

)%

Organic Growth 13

(3.5

)%

(5.5

)%

Extra Week in 2022 (53-week year)

(7.0

)%

(1.8

)%

M&A

4.4

%

3.3

%

Constant Currency

(6.1

)%

(4.0

)%

F/X

0.3

%

(2.4

)%

Total H.B. Fuller Net Revenue Growth

(5.8

)%

(6.4

)%

Net revenue growth versus 2022

Three Months Ended

December 2, 2023

Extra
Week

in 2022

Net
Revenue

F/X

Constant
Currency

M&A

(53-week
year)

Organic
Growth 13

Hygiene, Health and Consumable Adhesives

(7.3

)%

(0.2

)%

(7.1

)%

7.4

%

(7.0

)%

(7.5

)%

Engineering Adhesives

(7.4

)%

0.7

%

(8.1

)%

0.4

%

(7.1

)%

(1.4

)%

Construction Adhesives

5.4

%

0.8

%

4.6

%

6.4

%

(6.8

)%

5.0

%

Total H.B. Fuller

(5.8

)%

0.3

%

(6.1

)%

4.4

%

(7.0

)%

(3.5

)%

Net revenue growth versus 2022

Year Ended

December 2, 2023

Extra
Week

in 2022

Net
Revenue

F/X

Constant
Currency

M&A

(53-week
year)

Organic
Growth 13

Hygiene, Health and Consumable Adhesives

(5.6

)%

(3.3

)%

(2.3

)%

4.6

%

(1.8

)%

(5.1

)%

Engineering Adhesives

(6.8

)%

(2.0

)%

(4.8

)%

1.2

%

(1.8

)%

(4.2

)%

Construction Adhesives

(7.7

)%

(0.5

)%

(7.2

)%

5.4

%

(1.6

)%

(11.0

)%

Total H.B. Fuller

(6.4

)%

(2.4

)%

(4.0

)%

3.3

%

(1.8

)%

(5.5

)%

13 We use the term “organic revenue” to refer to net revenue, excluding the effect of foreign currency changes and acquisitions and divestitures. Organic growth reflects adjustments for the impact of period-over-period changes in foreign currency exchange rates on revenues and the revenues associated with acquisitions and divestitures.

CONSOLIDATED BALANCE SHEETS

H.B. Fuller Company and Subsidiaries

(In thousands, except share and per share amounts)

December 2,

December 3,

2023

2022

Assets

Current assets:

Cash and cash equivalents

$

179,453

$

79,910

Trade receivables, net

577,932

607,365

Inventories

442,040

491,781

Other current assets

112,678

120,319

Total current assets

1,312,103

1,299,375

Property, plant and equipment, net

824,655

733,667

Goodwill

1,486,512

1,392,627

Other intangibles, net

729,140

702,092

Other assets

371,165

335,868

Total assets

$

4,723,575

$

4,463,629

Liabilities, non-controlling interest and total equity

Current liabilities:

Notes payable

$

1,841

$

28,860

Current maturities of long-term debt

-

-

Trade payables

439,700

460,669

Accrued compensation

95,680

108,328

Income taxes payable

47,688

18,530

Other accrued expenses

107,902

89,345

Total current liabilities

692,811

705,732

Long-term debt, net of current maturities

1,836,590

1,736,256

Accrued pension liabilities

50,189

52,561

Other liabilities

388,072

358,286

Total liabilities

2,967,662

2,852,835

Commitments and contingencies (Note 14)

Equity:

H.B. Fuller stockholders' equity:

Preferred stock (no shares outstanding) Shares authorized – 10,045,900

-

-

Common stock, par value $1.00 per share, Shares authorized – 160,000,000, Shares outstanding – 54,092,987 and 53,676,576 for 2023 and 2022, respectively

54,093

53,677

Additional paid-in capital

301,485

266,491

Retained earnings

1,842,507

1,741,359

Accumulated other comprehensive loss

(442,880

)

(451,357

)

Total H.B. Fuller stockholders' equity

1,755,205

1,610,170

Non-controlling interest

708

624

Total equity

1,755,913

1,610,794

Total liabilities, non-controlling interest and total equity

$

4,723,575

$

4,463,629

CONSOLIDATED STATEMENTS of CASH FLOWS

H.B. Fuller Company and Subsidiaries

(In thousands)

Fiscal Years

December 2,

December 3,

November 27,

2023

2022

2021

Cash flows from operating activities:

Net income including non-controlling interest

$

144,988

$

180,407

$

161,475

Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:

Depreciation

80,327

72,593

72,106

Amortization

79,514

74,383

71,068

Deferred income taxes

(25,114

)

(15,230

)

16,192

Income from equity method investments, net of dividends received

1,259

(9

)

2,776

Loss (gain) on sale of assets

59

(1,195

)

648

Share-based compensation

19,911

24,368

22,366

Pension and other postretirement benefit plan contributions

(4,346

)

(3,009

)

(3,840

)

Pension and other postretirement benefit plan income

(18,591

)

(24,021

)

(28,662

)

Debt issuance cost write-off

2,689

-

-

Mark to market adjustment related to contingent consideration liabilities

2,893

-

2,300

Change in assets and liabilities, net of effects of acquisitions:

Trade receivables, net

68,721

(24,753

)

(124,849

)

Inventories

72,576

(55,772

)

(135,351

)

Other assets

(7,927

)

46,499

(79,097

)

Trade payables

(57,752

)

(22,629

)

176,337

Accrued compensation

(13,836

)

1,135

27,741

Other accrued expenses

(3,070

)

6,303

1,186

Income taxes payable

41,190

(12,873

)

(4,137

)

Other liabilities

22,918

4,104

(73,508

)

Other

(28,011

)

6,213

108,566

Net cash provided by operating activities

378,398

256,514

213,317

Cash flows from investing activities:

Purchased property, plant and equipment

(119,137

)

(129,964

)

(96,089

)

Purchased businesses, net of cash acquired

(205,093

)

(250,807

)

(5,445

)

Proceeds from sale of property, plant and equipment

5,029

1,556

2,896

Cash received from government grant

-

3,928

5,800

Cash outflow related to government grant

-

-

(1,822

)

Net cash used in investing activities

(319,201

)

(375,287

)

(94,660

)

Cash flows from financing activities:

Proceeds from issuance of long-term debt

2,233,300

335,000

-

Repayment of long-term debt

(2,126,450

)

(159,500

)

(156,500

)

Payment of debt issue costs

(10,214

)

(600

)

-

Net (payment on) proceeds from notes payable

(28,674

)

3,455

9,346

Dividends paid

(43,395

)

(39,207

)

(34,859

)

Contingent consideration payment

(1,477

)

(5,000

)

(1,700

)

Proceeds from stock options exercised

14,619

30,122

32,325

Repurchases of common stock

(2,567

)

(3,950

)

(2,682

)

Net cash provided by (used in) financing activities

35,142

160,320

(154,070

)

Effect of exchange rate changes on cash and cash equivalents

5,204

(23,423

)

(3,335

)

Net change in cash and cash equivalents

99,543

18,124

(38,748

)

Cash and cash equivalents at beginning of year

79,910

61,786

100,534

Cash and cash equivalents at end of year

$

179,453

$

79,910

$

61,786

View source version on businesswire.com: https://www.businesswire.com/news/home/20240117554213/en/

Steven Brazones
Investor Relations Contact
651-236-5060

Stock Information

Company Name: H. B. Fuller Company
Stock Symbol: FUL
Market: NYSE
Website: hbfuller.com

Menu

FUL FUL Quote FUL Short FUL News FUL Articles FUL Message Board
Get FUL Alerts

News, Short Squeeze, Breakout and More Instantly...